Summary
The global Mrna Vaccine And Therapeutics Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Mrna Vaccine And Therapeutics Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Mrna Vaccine And Therapeutics Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Argos Therapeutics
- BioNTech
- CureVac
- eTheRNA
- Ethris
- In-Cell-Art
- Moderna Therapeutics
- Sangamo Therapeutics
- Tiba Biotechnology
- Translate Bio
By the Product Type, the market is primarily segmented into:
- Infectious Disease
- Cancer
- Others
- Market segment by Application, split into
- Hospital
- Research Institual
By Applications, the market is segmented into:
- Hospital
- Research Institual
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Mrna Vaccine And Therapeutics Market Report:
- To assess the size of the market by value and volume
- Analyze the Mrna Vaccine And Therapeutics Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Mrna Vaccine And Therapeutics Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Mrna Vaccine And Therapeutics Market
The Mrna Vaccine And Therapeutics Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Mrna Vaccine And Therapeutics Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Others
1.5 Market by Application
1.5.1 Global mRNA Vaccine And Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Research Institual
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 mRNA Vaccine And Therapeutics Market Perspective (2015-2026)
2.2 mRNA Vaccine And Therapeutics Growth Trends by Regions
2.2.1 mRNA Vaccine And Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 mRNA Vaccine And Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 mRNA Vaccine And Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key mRNA Vaccine And Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top mRNA Vaccine And Therapeutics Players by Market Size
3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2015-2020)
3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global mRNA Vaccine And Therapeutics Market Concentration Ratio
3.2.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2019
3.3 mRNA Vaccine And Therapeutics Key Players Head office and Area Served
3.4 Key Players mRNA Vaccine And Therapeutics Product Solution and Service
3.5 Date of Enter into mRNA Vaccine And Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2021-2026)
5 mRNA Vaccine And Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America mRNA Vaccine And Therapeutics Market Size (2015-2020)
6.2 mRNA Vaccine And Therapeutics Key Players in North America (2019-2020)
6.3 North America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
6.4 North America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe mRNA Vaccine And Therapeutics Market Size (2015-2020)
7.2 mRNA Vaccine And Therapeutics Key Players in Europe (2019-2020)
7.3 Europe mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
7.4 Europe mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China mRNA Vaccine And Therapeutics Market Size (2015-2020)
8.2 mRNA Vaccine And Therapeutics Key Players in China (2019-2020)
8.3 China mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
8.4 China mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan mRNA Vaccine And Therapeutics Market Size (2015-2020)
9.2 mRNA Vaccine And Therapeutics Key Players in Japan (2019-2020)
9.3 Japan mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
9.4 Japan mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia mRNA Vaccine And Therapeutics Market Size (2015-2020)
10.2 mRNA Vaccine And Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India mRNA Vaccine And Therapeutics Market Size (2015-2020)
11.2 mRNA Vaccine And Therapeutics Key Players in India (2019-2020)
11.3 India mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
11.4 India mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America mRNA Vaccine And Therapeutics Market Size (2015-2020)
12.2 mRNA Vaccine And Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Argos Therapeutics
13.1.1 Argos Therapeutics Company Details
13.1.2 Argos Therapeutics Business Overview and Its Total Revenue
13.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction
13.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020))
13.1.5 Argos Therapeutics Recent Development
13.2 BioNTech
13.2.1 BioNTech Company Details
13.2.2 BioNTech Business Overview and Its Total Revenue
13.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction
13.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.2.5 BioNTech Recent Development
13.3 CureVac
13.3.1 CureVac Company Details
13.3.2 CureVac Business Overview and Its Total Revenue
13.3.3 CureVac mRNA Vaccine And Therapeutics Introduction
13.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.3.5 CureVac Recent Development
13.4 eTheRNA
13.4.1 eTheRNA Company Details
13.4.2 eTheRNA Business Overview and Its Total Revenue
13.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction
13.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.4.5 eTheRNA Recent Development
13.5 Ethris
13.5.1 Ethris Company Details
13.5.2 Ethris Business Overview and Its Total Revenue
13.5.3 Ethris mRNA Vaccine And Therapeutics Introduction
13.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.5.5 Ethris Recent Development
13.6 In-Cell-Art
13.6.1 In-Cell-Art Company Details
13.6.2 In-Cell-Art Business Overview and Its Total Revenue
13.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction
13.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.6.5 In-Cell-Art Recent Development
13.7 Moderna Therapeutics
13.7.1 Moderna Therapeutics Company Details
13.7.2 Moderna Therapeutics Business Overview and Its Total Revenue
13.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction
13.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.7.5 Moderna Therapeutics Recent Development
13.8 Sangamo Therapeutics
13.8.1 Sangamo Therapeutics Company Details
13.8.2 Sangamo Therapeutics Business Overview and Its Total Revenue
13.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction
13.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.8.5 Sangamo Therapeutics Recent Development
13.9 Tiba Biotechnology
13.9.1 Tiba Biotechnology Company Details
13.9.2 Tiba Biotechnology Business Overview and Its Total Revenue
13.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction
13.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.9.5 Tiba Biotechnology Recent Development
13.10 Translate Bio
13.10.1 Translate Bio Company Details
13.10.2 Translate Bio Business Overview and Its Total Revenue
13.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction
13.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2015-2020)
13.10.5 Translate Bio Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
List of Tables
Table 1. mRNA Vaccine And Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue
Table 3. Ranking of Global Top mRNA Vaccine And Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Infectious Disease
Table 6. Key Players of Cancer
Table 7. Key Players of Others
Table 8. Global mRNA Vaccine And Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global mRNA Vaccine And Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global mRNA Vaccine And Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global mRNA Vaccine And Therapeutics Market Share by Regions (2015-2020)
Table 12. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global mRNA Vaccine And Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. mRNA Vaccine And Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key mRNA Vaccine And Therapeutics Players
Table 19. Global mRNA Vaccine And Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global mRNA Vaccine And Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2019)
Table 22. Global mRNA Vaccine And Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players mRNA Vaccine And Therapeutics Product Solution and Service
Table 25. Date of Enter into mRNA Vaccine And Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global mRNA Vaccine And Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global mRNA Vaccine And Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global mRNA Vaccine And Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020)
Table 35. North America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America mRNA Vaccine And Therapeutics Market Share by Type (2015-2020)
Table 37. North America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America mRNA Vaccine And Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020)
Table 41. Europe mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe mRNA Vaccine And Therapeutics Market Share by Type (2015-2020)
Table 43. Europe mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe mRNA Vaccine And Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020)
Table 47. China mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China mRNA Vaccine And Therapeutics Market Share by Type (2015-2020)
Table 49. China mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China mRNA Vaccine And Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020)
Table 53. Japan mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan mRNA Vaccine And Therapeutics Market Share by Type (2015-2020)
Table 55. Japan mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan mRNA Vaccine And Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia mRNA Vaccine And Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia mRNA Vaccine And Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020)
Table 65. India mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India mRNA Vaccine And Therapeutics Market Share by Type (2015-2020)
Table 67. India mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India mRNA Vaccine And Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players mRNA Vaccine And Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players mRNA Vaccine And Therapeutics Market Share (2019-2020)
Table 71. Central & South America mRNA Vaccine And Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America mRNA Vaccine And Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America mRNA Vaccine And Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America mRNA Vaccine And Therapeutics Market Share by Application (2015-2020)
Table 75. Argos Therapeutics Company Details
Table 76. Argos Therapeutics Business Overview
Table 77. Argos Therapeutics Product
Table 78. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 79. Argos Therapeutics Recent Development
Table 80. BioNTech Company Details
Table 81. BioNTech Business Overview
Table 82. BioNTech Product
Table 83. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 84. BioNTech Recent Development
Table 85. CureVac Company Details
Table 86. CureVac Business Overview
Table 87. CureVac Product
Table 88. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 89. CureVac Recent Development
Table 90. eTheRNA Company Details
Table 91. eTheRNA Business Overview
Table 92. eTheRNA Product
Table 93. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 94. eTheRNA Recent Development
Table 95. Ethris Company Details
Table 96. Ethris Business Overview
Table 97. Ethris Product
Table 98. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 99. Ethris Recent Development
Table 100. In-Cell-Art Company Details
Table 101. In-Cell-Art Business Overview
Table 102. In-Cell-Art Product
Table 103. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 104. In-Cell-Art Recent Development
Table 105. Moderna Therapeutics Company Details
Table 106. Moderna Therapeutics Business Overview
Table 107. Moderna Therapeutics Product
Table 108. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 109. Moderna Therapeutics Recent Development
Table 110. Sangamo Therapeutics Business Overview
Table 111. Sangamo Therapeutics Product
Table 112. Sangamo Therapeutics Company Details
Table 113. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 114. Sangamo Therapeutics Recent Development
Table 115. Tiba Biotechnology Company Details
Table 116. Tiba Biotechnology Business Overview
Table 117. Tiba Biotechnology Product
Table 118. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 119. Tiba Biotechnology Recent Development
Table 120. Translate Bio Company Details
Table 121. Translate Bio Business Overview
Table 122. Translate Bio Product
Table 123. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2015-2020) (Million US$)
Table 124. Translate Bio Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Vaccine And Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Infectious Disease Features
Figure 3. Cancer Features
Figure 4. Others Features
Figure 5. Global mRNA Vaccine And Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Research Institual Case Studies
Figure 8. mRNA Vaccine And Therapeutics Report Years Considered
Figure 9. Global mRNA Vaccine And Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global mRNA Vaccine And Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global mRNA Vaccine And Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Players in 2019
Figure 14. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2019
Figure 16. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America mRNA Vaccine And Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 25. BioNTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 27. CureVac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 29. eTheRNA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 31. Ethris Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 33. In-Cell-Art Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 35. Moderna Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 37. Sangamo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 39. Tiba Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 41. Translate Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Request Discount 
Inquire Before Buy
